InMode (INMD) Net Cash Flow Growth (3y) (2021 - 2026)
InMode (INMD) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 269.22% |
| 10 | InMode | 912.82 Mn | 497.65 Mn | 71.52 Mn | -67.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 177.20% |
| Dec 31, 2025 | 36.87% |
| Sep 30, 2025 | 78.02% |
| Jun 30, 2025 | 15.33% |
| Mar 31, 2025 | 24.74% |
| Dec 31, 2024 | -115.36% |
| Sep 30, 2024 | 112.34% |
| Jun 30, 2024 | -109.26% |
| Mar 31, 2024 | -82.13% |
| Dec 31, 2023 | 181.87% |
| Sep 30, 2023 | -105.59% |
| Jun 30, 2023 | 50.82% |
| Mar 31, 2023 | -111.10% |
| Dec 31, 2022 | 88.94% |
| Sep 30, 2022 | -35.75% |
| Jun 30, 2022 | 65.31% |
| Mar 31, 2022 | -59.00% |
| Dec 31, 2021 | -29.99% |
| Sep 30, 2021 | 37.68% |
| Jun 30, 2021 | -32.29% |